Showing results (381-390 of 1,793) with videos related to
Sort By:
Pageof 180
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1985
Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3bG D Ross, J A Cain, P J LachmannOikos (Copenhagen, Denmark)|April 7, 2015
The fitness value of informationMatina C Donaldson-Matasci, Carl T Bergstrom, Michael LachmannJournal of Immunology (Baltimore, Md. : 1950)|October 1, 1979
Activation of complement by Schistosoma mansoni schistosomula: killing of parasites by the alternative pathway and requirement of IgG for classical pathway activationF Santoro, P J Lachmann, A Capron, et al.Immunology|February 1, 1992
The targeting of T-helper cells and tumourcidal macrophages to a B-cell lymphoma using a PPD-monoclonal antibody heteroconjugateA M Montgomery, M G Wing, P J LachmannInternational Archives of Allergy and Applied Immunology|January 1, 1980
The coagglutination phenomenon of Bordet and Gengou involves a reaction between antibody-aggregated fourth component of complement and a receptor on guniea pig red cellsR R Coombs, A B Wilson, P J LachmannClinical Radiology|March 1, 1985
Spina bifida occulta: lesion or anomaly?D Boone, D Parsons, S M Lachmann, et al.Rheumatology (Oxford, England)|March 25, 2025
Systemic autoinflammatory disease diagnoses in a single year from a UK national referral centreHugh Caterson, Charalampia Papadopoulou, Claire Peet, et al.Theoretical Biology & Medical Modelling|July 13, 2013
On the role of resonance in drug failure under HIV treatment interruptionLeonardo Oña, Roger D Kouyos, Michael Lachmann, et al.The Biochemical Journal|May 15, 1988
Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation productsT C Farries, P J Lachmann, R A HarrisonInternational Journal of Molecular Sciences|April 18, 2014
Quality control and stability studies with the monoclonal antibody, trastuzumab: application of 1D- vs. 2D-gel electrophoresisDashnor Nebija, Christian R Noe, Ernst Urban, et al.Pageof 180